BORASCHI, DIANA
 Distribuzione geografica
Continente #
AS - Asia 2.471
NA - Nord America 2.319
EU - Europa 607
SA - Sud America 482
Continente sconosciuto - Info sul continente non disponibili 132
AF - Africa 51
OC - Oceania 2
Totale 6.064
Nazione #
US - Stati Uniti d'America 2.187
SG - Singapore 1.090
CN - Cina 481
BR - Brasile 369
HK - Hong Kong 290
VN - Vietnam 264
IT - Italia 210
FR - Francia 150
KR - Corea 79
BD - Bangladesh 70
CA - Canada 62
FI - Finlandia 47
JP - Giappone 45
DE - Germania 44
IN - India 39
GB - Regno Unito 38
NL - Olanda 36
CO - Colombia 29
AR - Argentina 26
MX - Messico 21
EC - Ecuador 19
IL - Israele 16
SA - Arabia Saudita 16
ID - Indonesia 13
PL - Polonia 12
CR - Costa Rica 11
MA - Marocco 11
TR - Turchia 11
VE - Venezuela 11
AT - Austria 9
CL - Cile 9
ZA - Sudafrica 9
EG - Egitto 8
ES - Italia 8
JM - Giamaica 8
LT - Lituania 8
MY - Malesia 8
PE - Perù 8
NP - Nepal 7
UZ - Uzbekistan 7
GT - Guatemala 6
IE - Irlanda 6
KE - Kenya 6
TN - Tunisia 6
UA - Ucraina 6
IQ - Iraq 5
KZ - Kazakistan 5
PA - Panama 5
NI - Nicaragua 4
PH - Filippine 4
PK - Pakistan 4
PY - Paraguay 4
SE - Svezia 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
GR - Grecia 3
HN - Honduras 3
RS - Serbia 3
SN - Senegal 3
TH - Thailandia 3
AL - Albania 2
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
GA - Gabon 2
GP - Guadalupe 2
HR - Croazia 2
KW - Kuwait 2
OM - Oman 2
PT - Portogallo 2
RU - Federazione Russa 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CH - Svizzera 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GF - Guiana Francese 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
MM - Myanmar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 5.926
Città #
Singapore 647
Santa Clara 466
Hong Kong 289
San Jose 206
Hefei 193
Ashburn 167
Lauterbourg 116
Council Bluffs 114
Beijing 95
Ho Chi Minh City 87
Hanoi 82
Seoul 78
Dallas 69
Los Angeles 55
Princeton 53
Tokyo 32
Abbeville 31
São Paulo 31
New York 30
Milan 27
Helsinki 26
Buffalo 21
Rome 20
Frankfurt am Main 19
Chicago 17
Toronto 17
Atlanta 14
Lappeenranta 13
Phoenix 13
Marigliano 12
Naples 12
Philadelphia 12
Rio de Janeiro 12
Florence 11
Houston 11
Minamishinagawa 11
Da Nang 10
London 10
Orem 10
Bogotá 9
Brasília 9
Brooklyn 9
Cairo 9
Campinas 9
Chennai 9
Las Vegas 9
Montreal 9
Newark 9
Nuremberg 9
Porto Alegre 9
Charlotte 8
Guayaquil 8
Riyadh 8
Turku 8
Warsaw 8
Dhaka 7
Haiphong 7
Medellín 7
Miami 7
San José 7
Tashkent 7
The Bronx 7
Belo Horizonte 6
Brescia 6
Detroit 6
Guatemala City 6
Hayward 6
Hải Dương 6
Lima 6
Ribeirão Preto 6
Washington 6
Bengaluru 5
Biên Hòa 5
Campo Grande 5
Changsha 5
Columbus 5
Denver 5
Falkenstein 5
Jeddah 5
Kingston 5
Memphis 5
Nairobi 5
Nha Trang 5
Nova Iguaçu 5
Oklahoma City 5
Queens 5
Riverside 5
San Francisco 5
Spartanburg 5
São Gonçalo 5
Thái Nguyên 5
Vienna 5
Bakersfield 4
Bauru 4
Boardman 4
Boston 4
Caracas 4
Casablanca 4
Curitiba 4
Dublin 4
Totale 3.518
Nome #
Interaction of nanoparticles with endotoxin Importance in nanosafety testing and exploitation for endotoxin binding 113
Engineered nanoparticles. How brain friendly is this new guest? 113
Towards bio-compatible magnetic nanoparticles Immune-related effects, in-vitro internalization, and in-vivo bio-distribution of zwitterionic ferrite nanoparticles with unexpected renal clearance 103
Profiling the Course of Resolving vs. Persistent Inflammation in Human Monocytes: The Role of IL-1 Family Molecules 89
Personalised Profiling of Innate Immune Memory Induced by Nano-Imaging Particles in Human Monocytes 85
Addressing Nanomaterial Immunosafety by Evaluating Innate Immunity across Living Species 84
Probing the immune responses to nanoparticles across environmental species. A perspective of the EU Horizon 2020 project PANDORA 81
Methodological Approaches To Assess Innate Immunity and Innate Memory in Marine Invertebrates and Humans 81
Innate Memory Reprogramming by Gold Nanoparticles Depends on the Microbial Agents That Induce Memory 78
Regulation of innate receptors and IL-18 in hepatocytic cells is altered by environmental particles. 77
Direct LC-MS/MS Analysis of Extra- and Intracellular Glycerophosphoinositol in Model Cancer Cell Lines 76
Endotoxin contamination: a key element in the interpretation of nanosafety studies 74
Induction of Innate Immune Memory by Engineered Nanoparticles: A Hypothesis That May Become True 74
IL-1 Family 72
Structural disconnectivity in postoperative delirium: A perioperative two-center cohort study in older patients 70
Innate and germline immune memory: specificity and heritability of the ancient immune mechanisms for adaptation and survival 69
Interaction between nanomaterials and the innate immune system across evolution 67
Development of biologicals for the therapy of lupus erythematosus 66
Effects of nano-and microplastics in the development of immune memory in the ascidian Ciona robusta 66
IL-1 family cytokines and receptors in IgG4-related disease. 65
Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression? 65
Environmental stress and nanoplastics' effects on Ciona robusta: regulation of immune/stress-related genes and induction of innate memory in pharynx and gut 65
Primary and memory response of human monocytes to vaccines: Role of nanoparticulate antigens in inducing innate memory 64
Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice 62
A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses 61
Interaction between Macrophages and Nanoparticles: In Vitro 3D Cultures for the Realistic Assessment of Inflammatory Activation and Modulation of Innate Memory 60
Poverty-Related Disease College: a virtual African-European network to build research capacity. 57
Induction of Innate Immune Memory by Engineered Nanoparticles in Monocytes/Macrophages: From Hypothesis to Reality 57
Concern-driven integrated approaches to nanomaterial testing and assessment - report of the NanoSafety Cluster Working Group 10 56
ImmuNapoli 2019 56
New approaches to anti-bacterial mucosal immunization through targeted modulation of innate immunity mechanisms 55
The association between frailty and MRI features of cerebral small vessel disease 55
Robust Immune Response Induced by Schistosoma mansoni TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles 55
Suitability of in vitro Immunotoxicity Methods for Assesment of Nanomaterials 53
Innate Immune Memory in Invertebrate Metazoans: A Critical Appraisal 53
IL-1 family cytokines and monocytes/macrophages in the regulation of inflammation. 53
Cytokines and soluble receptors of the IL-1 family in Schnitzler syndrome. 51
In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii 50
Cerebral microbleeds are not associated with postoperative delirium and postoperative cognitive dysfunction in older individuals 50
The IL-1 family cytokines and receptors in autoimmune diseases 50
Surface Exposure of PEG and Amines on Biodegradable Nanoparticles as a Strategy to Tune Their Interaction with Protein-Rich Biological Media 48
IL-1 family nomenclature 47
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 46
IL-1 family cytokines and soluble receptors in systemic lupus erythematosus 46
Assessing the Immunosafety of Engineered Nanoparticles with a Novel in Vitro Model Based on Human Primary Monocytes. 44
Cytokine gene transfer in the therapy of autoimmune diseases 44
Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles 44
Assessing Immunological Memory in the Solitary Ascidian Ciona robusta 43
Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles 43
From monocytes to M1/M2 macrophages: Phenotypical vs. functional differentiation 42
Transcriptomic profiling of the development of the inflammatory response in human monocytes in vitro 42
The Impact of Nanoparticles on Innate Immune Activation by Live Bacteria 42
Induction of long-term immunity against Respiratory Syncytial Virus glycoprotein by an osmotic polymer nanocarrier 41
Endotoxin contamination in nanomaterials leads to the misinterpretation of immunosafety results 40
Cytokine receptors 39
Bovine colon organoids: From 3D bioprinting to cryopreserved multi-well screening platforms 38
Pharmacological strategies using biologics as immunomodulatory agents 38
Free circulating interleukin-18 is increased in Schnitzler syndrome: a new autoinflammatory disease? 38
Innate Immune Memory: The Latest Frontier of Adjuvanticity 38
Plant-produced potato virus X chimeric particles displaying an influenza virus-derived peptide activate specific 37
Nanoparticles and the Immune System: Safety and Effects 37
The immunostimulatory effect of IL-1 beta in vivo is blocked by antisense peptides complementary to the loop sequence 163-171 37
Chimeric plant virus particles displaying an influenza virus-derived peptide activate specific CD8+ T cells in mice 37
Concepts for nano-delivery of therapeutic immunomodulatory agents 36
Exploring the interaction of nanomedicines with the human immune system, Assessing immunosafety and investigating preventive/therapeutic targeting. 36
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis 36
Nanoparticles and the immune system: safety and effects 36
Perspectives in immunopharmacology: The future of immunosuppression 36
Balance between autocrine IL-1² and caspases defines life vs. death of PMN 35
ImmuNapoli 2016 35
Assessing immunosafety of nanomaterials. Cell-based modelling of inflammatory responses to predict putative risks for human health 35
From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology. 35
The Gracefully Aging Immune System 34
IL-37: a new anti-inflammatory cytokine of the IL-1 family 34
Preface 34
Nanoparticles and innate immunity: new perspectives on host defence. 34
Nano-immunosafety: approaches to in vitro assessment 33
Towards nanotechnology regulation-Publish the unpublishable 33
Glycosylation enhances functional stability of the chemotactic cytokine CCL-2. 33
Specific immune response to HBsAg is enhanced by ²-glucan oligosaccharide containing an ±-(1 3)-linked bond, and biased towards M2/Th2 33
Oxidative stress and inflammation induced by environmental and psychological stressors: a biomarker perspective 33
REGULATION OF IL-1/IL-18 FAMILY CYTOKINES AND RECEPTORS BY ²-GLUCANS: PROMOTION OF NON-INFLAMMATORY RESPONSES IN EPITHELIAL CELLS AND MONOCYTES 33
Nanoparticles and Innate Immunity 33
Modulation of defence cell functions by nano-particles in vitro. 32
Innate immune memory: Time for adopting a correct terminology 32
THE PATHOLOGICAL ROLE OF IL-18 IN LYMPHOID ORGANS OF AUTOIMMUNE MRL lpr/lpr MICE 32
Interaction of engineered nanomaterials with the immune system: health related safety and possible benefits. 32
Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria 32
Vaccines of the Future: The Role of Inflammation and Adjuvanticity 32
Trascriptomic Profiling of the Development of the Inflammatory Response in Human Monocytes in vitro 32
Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria 31
Modulation of defence cell functions by nano-particles in vitro 31
How Innate and Adaptive Immunity Work 31
Nano-immunosafety. Where do we see gaps in our present knowledge? 31
Immunosafety of engineered nanoparticles: methods implementation for the development of nanomedicines 31
Optimising response to vaccination in the elderly: the case of influenza 31
The DIPNA project: a platform for the nanotoxicological investigations 31
IL-1 family nomenclature (vol 11, pg 973, 2010) 30
Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain 30
IL-18 cDNA vaccination protect mice from spontaneous lupus-like disease 30
Totale 4.900
Categoria #
all - tutte 21.609
article - articoli 14.310
book - libri 359
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.818
Totale 39.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202459 0 0 0 0 0 0 0 0 12 8 22 17
2024/20251.875 4 7 140 81 468 45 50 68 77 55 472 408
2025/20262.946 125 282 314 494 526 77 403 159 160 187 145 74
2026/20271.184 156 110 353 565 0 0 0 0 0 0 0 0
Totale 6.064